Alzheimer’s disease — what labs can tell you about your risk
This clip is from AMA #14: What lab tests can (and cannot) inform us about our overall objective of longevity,…
Why does Alzheimer’s disease affect more women than men?
This clip is from episode #138 – Lauren Miller Rogen and Richard Isaacson, M.D.: Alzheimer’s disease prevention—patient and doctor perspectives,…
The connection between sleep and Alzheimer’s disease
This audio clip is from episode #47 – Matthew Walker, Ph.D., on sleep – Part I of III: Dangers of…
The connection between sleep and heart disease
This audio clip is from episode #48 with Matthew Walker, Ph.D., on sleep – Part II of III: Heart disease, cancer,…
Fighting cancer and improving immune function with sleep
This audio clip is from episode #48 with Matthew Walker, Ph.D., on sleep – Part II of III: Heart disease,…
Why sleep is the best insurance policy for lifespan and healthspan
This video clip is from episode #58 – AMA with sleep expert, Matthew Walker, Ph.D.: Strategies for sleeping more, sleeping…
#213 ‒ Liquid biopsies and cancer detection | Max Diehn, M.D. Ph.D.
“I was frustrated by not being able to diagnose a recurrence earlier.” —Max Diehn
Cumulative effects of LDL-C reduction in mitigating cardiovascular risk
Atherosclerotic cardiovascular disease (ASCVD) is currently the leading cause of death in the U.S. One of the most effective ways to reduce risk of ASCVD mortality is reduction of apoB particle number, typically estimated by LDL cholesterol (LDL-C) concentrations.
Does exercise reduce the risk of Alzheimer’s disease?
This clip is from episode #18 – Richard Isaacson, M.D.: Alzheimer’s prevention, originally release on October 1, 2018.
Lp(a) and CVD risk & clinical tests to measure Lp(a)
This video clip is from episode #210 – Lp(a) and its impact on heart disease with Benoît Arsenault, Ph.D., originally…